Ovarian cancer
Also known as: Ovarian malignancy, Malignant ovarian neoplasm, Ovarian carcinoma, Epithelial ovarian cancer
Ovarian cancer encompasses a range of malignancies necessitating gynaecological oncology assessment, histological confirmation, and stage-directed management, typically comprising surgery and systemic therapy. TCM may be considered solely for supportive symptom care alongside conventional oncological management. A review of postoperative ovarian cancer care indicated that adjunctive TCM might mitigate chemotherapy-induced adverse effects and improve performance status; however, high heterogeneity and limited study quality limit confidence. Observed alterations in immunological markers do not establish survival benefits [1]. While a broader cancer review supports acupuncture for chemotherapy-induced nausea and vomiting, evidence specific to ovarian cancer remains lacking [4]. Research concerning endometriosis does not demonstrate benefit for ovarian cancer [2,3]. The traditional patterns and formulas included serve as traditional assessment frameworks and are not validated anticancer therapies or evidence-based prescriptions for this malignancy.
Plain-English one-pager you can print or hand to a patient. Free, no sign-in needed.
Lifestyle & Diet
- •Maintain a daily record of emesis, nausea, fluid intake, and bowel frequency for oncology review.
- •Prioritise small, frequent meals and seek early dietetic consultation if early satiety, anorexia, or significant weight loss occurs.
- •Balance periods of rest with light, individually cleared physical activity; cease exercise and seek advice upon the onset of dizziness, chest symptoms, or new pain.
- •Attend all scheduled follow-up consultations and provide the oncology team with a comprehensive list of all herbs, supplements, and complementary therapies currently in use.
Cautions & Contraindications
- •Do not replace or delay surgery, chemotherapy, maintenance treatment or oncology review with acupuncture or herbs. The supplied postoperative review evaluates adjunctive treatment and does not establish cancer control or survival benefit.[]
- •Defer needling during fever, suspected infection, active bleeding or clinically significant cytopenias until the oncology team clears treatment. Check current counts and local oncology thresholds. These are general safety precautions; the supplied acupuncture abstract does not define safe blood-count cut-offs.[]
- •Avoid needling through tumour sites, infected or irradiated damaged skin, recent surgical wounds, ports or drains; avoid abdominal needling with ascites, distension or uncertain anatomy. These general precautions are not specifically evaluated in the supplied CINV abstract.[]
- •Do not initiate herbal formulas without oncology-pharmacist review of systemic therapy, anticoagulants, renal and hepatic function and planned surgery. The supplied review does not establish the interaction safety of the listed formulas.[]
When to reassess or seek care again
Review within 7 days of starting supportive care and at each chemotherapy cycle. Record daily nausea on a 0–10 scale, vomiting episodes, rescue-antiemetic use, oral intake, bowel function, fatigue and sleep; monitor weight weekly when appropriate. Reassess benefit after 2–3 acupuncture visits and stop or modify care if there is no meaningful improvement. Escalate breakthrough vomiting, deteriorating intake or increasing symptoms promptly to oncology; red flags require immediate assessment rather than scheduled review.
Explore more diseases
Sources & Further Reading
Clinical guidance, red flags and safety notes on this page draw on the following current sources alongside the classical references above.
- Frontiers in medicine · 2026
- Drug design, development and therapy · 2026
- Journal of clinical medicine · 2026
- Frontiers in neurology · 2026
Educational reference for licensed practitioners. Not a substitute for individual clinical assessment. Refer to conventional care for any red-flag or undiagnosed presentation.
